A detailed history of Csenge Advisory Group transactions in Johnson & Johnson stock. As of the latest transaction made, Csenge Advisory Group holds 21,785 shares of JNJ stock, worth $3.18 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
21,785
Previous 21,912 0.58%
Holding current value
$3.18 Million
Previous $3.43 Million 0.35%
% of portfolio
0.2%
Previous 0.22%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$155.22 - $162.74 $19,712 - $20,667
-127 Reduced 0.58%
21,785 $3.45 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $342,014 - $373,209
-2,349 Reduced 9.68%
21,912 $3.43 Million
Q3 2023

Nov 01, 2023

SELL
$155.75 - $174.48 $797,595 - $893,512
-5,121 Reduced 17.43%
24,261 $3.78 Million
Q2 2023

Jul 20, 2023

BUY
$154.35 - $166.11 $370,594 - $398,830
2,401 Added 8.9%
29,382 $4.86 Million
Q1 2023

May 01, 2023

BUY
$151.05 - $180.26 $13,443 - $16,043
89 Added 0.33%
26,981 $4.18 Million
Q4 2022

Feb 10, 2023

SELL
$160.2 - $179.79 $35,083 - $39,374
-219 Reduced 0.81%
26,892 $4.75 Million
Q3 2022

Oct 04, 2022

BUY
$161.33 - $179.52 $163,104 - $181,494
1,011 Added 3.87%
27,111 $4.43 Million
Q2 2022

Jul 27, 2022

BUY
$168.19 - $186.01 $103,436 - $114,396
615 Added 2.41%
26,100 $4.63 Million
Q1 2022

May 09, 2022

SELL
$158.14 - $179.59 $512,689 - $582,230
-3,242 Reduced 11.29%
25,485 $4.52 Million
Q4 2021

Feb 10, 2022

BUY
$155.93 - $173.01 $411,187 - $456,227
2,637 Added 10.11%
28,727 $4.77 Million
Q3 2021

Oct 20, 2021

SELL
$161.5 - $179.47 $425,875 - $473,262
-2,637 Reduced 9.18%
26,090 $4.19 Million
Q2 2021

Jul 21, 2021

BUY
$159.48 - $171.07 $721,487 - $773,920
4,524 Added 18.69%
28,727 $4.77 Million
Q1 2021

Apr 28, 2021

BUY
$153.07 - $170.48 $876,631 - $976,338
5,727 Added 31.0%
24,203 $3.9 Million
Q4 2020

Jan 26, 2021

SELL
$137.11 - $157.38 $88,710 - $101,824
-647 Reduced 3.38%
18,476 $2.91 Million
Q3 2020

Nov 09, 2020

BUY
$140.38 - $153.83 $29,479 - $32,304
210 Added 1.11%
19,123 $2.8 Million
Q2 2020

Jul 17, 2020

BUY
$128.81 - $155.51 $620,864 - $749,558
4,820 Added 34.2%
18,913 $2.66 Million
Q1 2020

Apr 21, 2020

BUY
$111.14 - $153.99 $68,128 - $94,395
613 Added 4.55%
14,093 $1.85 Million
Q4 2019

Feb 05, 2020

BUY
$127.5 - $146.44 $271,192 - $311,477
2,127 Added 18.74%
13,480 $1.97 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $111,716 - $125,083
880 Added 8.4%
11,353 $1.47 Million
Q2 2019

Jul 30, 2019

SELL
$131.15 - $144.24 $38,426 - $42,262
-293 Reduced 2.72%
10,473 $1.46 Million
Q1 2019

May 07, 2019

BUY
$125.72 - $139.79 $166,076 - $184,662
1,321 Added 13.99%
10,766 $1.51 Million
Q4 2018

Feb 07, 2019

SELL
$122.84 - $147.84 $250,593 - $301,593
-2,040 Reduced 17.76%
9,445 $1.22 Million
Q3 2018

Nov 19, 2018

SELL
$121.58 - $142.88 $364,253 - $428,068
-2,996 Reduced 20.69%
11,485 $1.66 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $3,223 - $3,557
27 Added 0.19%
14,481 $1.76 Million
Q1 2018

May 10, 2018

SELL
$125.1 - $148.14 $19,265 - $22,813
-154 Reduced 1.05%
14,454 $1.85 Million
Q4 2017

Feb 15, 2018

BUY
$131.22 - $143.62 $129,776 - $142,040
989 Added 7.26%
14,608 $2.04 Million
Q3 2017

Oct 31, 2017

BUY
$129.47 - $135.38 $1.76 Million - $1.84 Million
13,619
13,619 $0

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.